Hosted on MSN1mon
Biohaven's troriluzole gains FDA priority review for SCAThe company is prepared to commercialize troriluzole in the U.S. upon potential approval in 2025. Dr. Melissa Beiner, SCA Clinical Development Lead at Biohaven, emphasized the urgency for SCA ...
The analyst also pointed out that SCA's commentary on reduced capital expenditures might be viewed favorably, considering the company's history of significant project spending in recent years.
Broadcaster SCA has lost its place in the All Ordinaries index, which tracks the performance of the ASX. The All Ordinaries ...
At SCA, Blair Woodcock has been promoted to head of regional content and Gold Coast general manager; Nick Unger is now head ...
Svenska Cellulosa Aktiebolaget SCA (publ), a forest products company, develops, produces, and sells forest, wood, pulp, and paper products worldwide. The company offers wood products to the home ...
Julian Movsesian is the president and founder of Capital Management Strategies, Inc. and CEO of Succession Capital ...
Digital audio revenues are up 48% on calendar 2023. The board of directors at SCA decided not to pay a half-year dividend as the company focuses on debt reduction. The company reported audio ...
SCA chief executive John Kelly told staff about the redundancies in a company-wide email yesterday. Kelly said that “challenging economic conditions and structural challenges” meant that the ...
Hermes International SCA is a France-based company. The Company is predominantly specialized in the designing, manufacturing, and marketing of luxury products. Its products are divided among leather ...
Sonatype Unveils Industry-First AI Software Composition Analysis (SCA) to Power AI-Driven Innovation
Sonatype is the first and only company providing an end-to-end AI SCA solution, ensuring that enterprises can adopt AI with the same level of safety and productivity as traditional open source.
SCA has promoted Blair Woodcock to head of regional content and Gold Coast general manager and Nick Unger to head of sales ...
The company is prepared to commercialize troriluzole in the U.S. upon potential approval in 2025. Dr. Melissa Beiner, SCA Clinical Development Lead at Biohaven, emphasized the urgency for SCA ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results